XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

SCHEDULE OF INVESTMENTS (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Cost method investment	$ 3,084,278	$ 3,084,278
Direct Dermatology Inc. [Member]
Cost method investment	1,000,000	1,000,000
Pixalere Healthcare Inc. [Member]
Cost method investment	$ 2,084,278	$ 2,084,278

X

- Definition

Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_OtherInvestmentsAndSecuritiesAtCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	dei_LegalEntityAxis=SMTI_DirectDermatologyIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=SMTI_PixalereHealthcareIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: